Inicio  /  Cancers  /  Vol: 15 Par: 14 (2023)  /  Artículo
ARTÍCULO
TITULO

Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer

Simon Ezban Grützmeier    
Bojan Kovacevic    
Peter Vilmann    
Charlotte Vestrup Rift    
Linea Cecilie Melchior    
Morten Orebo Holmström    
Lene Brink    
Hazem Hassan    
John Gásdal Karstensen    
Hanne Grossjohann    
Deepthi Chiranth    
Anders Toxværd    
Carsten Palnæs Hansen    
Estrid Høgdall    
Jane Preuss Hasselby and Pia Klausen    

Resumen

Pancreatic cancer is a devastating disease with a 5-year survival rate of 12%. Only about 20% of patients are candidates for curative surgery, while the majority receive palliative chemotherapy or best supportive care. Recently, testing chemotherapeutical agents on patient-derived 3-dimensional cultures (organoids) of cancer cells has provided hope that personalized treatment may soon become a reality. However, most of these models only include tumor cells and not cells of the supporting tissue, which have been shown to play a critical role in cancer progression. In this study, we created a co-culture including both tumor and stromal cells from endoscopic ultrasound-guided biopsies and showed that an interaction occurs between the cell types in our model. It may therefore be a step towards better prediction of therapeutic response in the future. We also discuss the limitations of creating these types of models by using endoscopic biopsies from primary tumors.

PÁGINAS
pp. 0 - 0
REVISTAS SIMILARES

 Artículos similares